Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Humacyte shares are continuing higher after the company on Monday announced it was granted Regenerative Medicine Advanced Therapy designation by the FDA for patients with advanced peripheral artery disease.

Author: Benzinga Newsdesk | July 02, 2024 07:11am

Posted In: HUMA